CHARACTERIZATION OF ADAPTIVE IMMUNE RESPONSE TO VACCINATION OR INFECTION USING IMMUNE REPERTOIRE SEQUENCING

Patent №

US 11,066,705

Granted

2021-07-20

Filed 2017

Owner

ADAPTIVE BIOTECHNOLOGIES CORP.

+2 more

Lab

AI components

1

hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

15529943

Methods of monitoring and measuring dynamic adaptive immune cell responses are provided. High-throughput sequencing of T cell receptor and immunoglobulin loci is used to characterize the breadth of an effector cell response to a stimulus, such as a vaccine or infection. Unique responding effector cell clones and abundance thereof can be determined. Additionally, methods for determining the contribution of responding effector cells to the immunological memory compartment are provided.

AI hardwareC12Q 1/6881C12Q 1/6883C12Q 1/6886C12Q 2600/156

AI classification

AI hardware0.57
Machine learning0.04
Natural language0.02
Vision0.01
Speech0.00
Knowledge representation0.00
Evolutionary computation0.00
Planning0.00

Ownership

ADAPTIVE BIOTECHNOLOGIES CORP.

assignment · 439730235

FRED HUTCHINSON CANCER RESEARCH CENTER

assignment · 439730374

FRED HUTCHINSON CANCER CENTER

merger · 609820053

Assignors

DEWITT, WILLIAM SUMNER, III, EMERSON, RYAN O.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC